Drs. Duff, Kauffman publish paper

Lancaster Labs’ director Dr. Jon S. Kauffman and manager Dr. Robert J. Duff as well as Jacek Cieslak, Andrzej Grajkowski and Serge L. Beaucage of the FDA-CDER, Division of Therapeutic Proteins, published “The 4-(N-Dichloroacetyl-N-methylamino) benzyloxymethyl Group for 2’-Hydroxyl Protection of Ribonucleosides in the Solid-Phase Synthesis of Oligoribonucleotides,” in the Journal of Organic Chemistry, 2774-2783, 2008.

LabAccess.com